Regarding genetically epilepsy-prone rats (GEPR-3s), CPZ (a TRPV1 antagonist) reduced seizure severity in a dose-dependent manner in male rats and in female rats CPZ suppressed seizure susceptibility [396]. The gene discussed is TRPV1; the disease is epilepsy.